Filtros de búsqueda

Lista de obras de Nicole C Ammerman

<i>In Vitro</i> Activity of Bedaquiline and Imipenem against Actively Growing, Nutrient-Starved, and Intracellular Mycobacterium abscessus

artículo científico publicado en 2021

A typhus group-specific protease defies reductive evolution in rickettsiae.

artículo científico publicado en 2009

Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitor

artículo científico publicado en 2013

Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection

artículo científico publicado en 2019

Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection

Adjuvant host-directed therapy with types 3 and 5 but not type 4 phosphodiesterase inhibitors shortens the duration of tuberculosis treatment

artículo científico publicado en 2013

An Adaptive Biosystems Engineering Approach towards Modeling the Soluble-to-Insoluble Phase Transition of Clofazimine

artículo científico publicado en 2021

An anomalous type IV secretion system in Rickettsia is evolutionarily conserved

artículo científico publicado en 2009

Antibiotics. Targeting DnaN for tuberculosis therapy using novel griselimycins

artículo científico publicado en 2015

Assessment of clofazimine activity in a second-line regimen for tuberculosis in mice.

artículo científico publicado en 2013

Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis

artículo científico publicado en 2015

Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations

artículo científico publicado en 2015

Clofazimine Contributes Sustained Antimicrobial Activity after Treatment Cessation in a Mouse Model of Tuberculosis Chemotherapy.

artículo científico publicado en 2016

Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo.

artículo científico publicado en 2016

Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis

artículo científico publicado en 2015

Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study

artículo científico publicado en 2021

Dose-ranging activity of the newly registered antituberculosis drug bedaquiline (TMC207)

artículo científico publicado en 2013

Functional characterization of a phospholipase A(2) homolog from Rickettsia typhi.

artículo científico publicado en 2010

Gene expression of Mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments.

artículo científico publicado en 2012

Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.

artículo científico publicado en 2018

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy.

artículo científico publicado en 2012

In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates

artículo científico publicado en 2019

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

artículo científico publicado en 2017

Indoleamides are active against drug-resistant Mycobacterium tuberculosis

artículo científico publicado en 2013

Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis.

artículo científico publicado en 2012

Louse- and flea-borne rickettsioses: biological and genomic analyses.

artículo científico publicado en 2008

Model-Based Meta-Analysis of Relapsing Mouse Model Studies from the Critical Path to Tuberculosis Drug Regimens Initiative Database

artículo científico publicado en 2022

Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide ⬇️

artículo científico publicado el 27 de agosto de 2012

Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation

artículo científico publicado en 2015

Non-classical transpeptidases yield insight into new antibacterials

artículo científico publicado en 2016

Plasmids and rickettsial evolution: insight from Rickettsia felis

artículo científico publicado en 2007

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice

artículo científico publicado en 2014

Risk of tuberculosis reactivation with tofacitinib (CP-690550).

artículo científico publicado en 2012

Rv2190c, an NlpC/P60 Family Protein, Is Required for Full Virulence of Mycobacterium tuberculosis ⬇️

artículo científico publicado el 31 de agosto de 2012

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer

scientific article published on 13 August 2018

Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model

artículo científico publicado en 2012

Surface proteome analysis and characterization of surface cell antigen (Sca) or autotransporter family of Rickettsia typhi.

artículo científico publicado en 2012

TolC-dependent secretion of an ankyrin repeat-containing protein of Rickettsia typhi

artículo científico publicado en 2012

Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis

scientific article published on 24 May 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda